Chromocell Therapeutics Corp (CHRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CHRO | AMGN | VRTX | REGN | GSK |
| Company | Chromocell Therapeutics Corp | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3900 | 298.49 | 479.13 | 1,036.52 | 40.43 |
| High | 1.4600 | 299.35 | 479.15 | 1,038.22 | 40.50 |
| Low | 1.2600 | 297.33 | 474.83 | 1,032.78 | 40.36 |
| Last | 1.3000 | 297.65 | 475.41 | 1,029.38 | 40.47 |
| Change | -0.0500 | -0.97 | -5.32 | -7.14 | -0.18 |
| % Change | -3.70% | -0.32% | -1.11% | -0.69% | -0.44% |
| Volume | 7,900 | 74,999 | 60,481 | 29,352 | 102,566 |
| 20-Day Average Volume | 12,005 | 2,079,769 | 1,129,686 | 364,462 | 3,902,532 |
| Previous Close | 1.3500 | 298.62 | 480.73 | 1,036.52 | 40.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4637 | 304.43 | 465.09 | 997.56 | 42.75 |
| 20-Day Raw Stochastic | 4.65% | 10.67% | 77.71% | 92.00% | 0.37% |
| 20-Day Relative Strength | 38.66% | 48.96% | 65.37% | 68.87% | 38.02% |
| Weighted Alpha | N/A | +26.04 | +40.92 | +35.56 | +9.81 |
| Today's Opinion | N/A | 88% Buy | 100% Buy | 88% Buy | 24% Buy |
| Previous Opinion | N/A | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | N/A | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.45% since 06/07/24 | -2.34% since 06/10/24 | -1.69% since 06/10/24 | +3.36% since 06/10/24 | -2.20% since 06/10/24 |
| Low | 1.2600 on 06/14/24 | 295.30 on 06/13/24 | 472.61 on 06/13/24 | 997.84 on 06/11/24 | 40.36 on 06/17/24 |
| High | 1.5500 on 06/11/24 | 303.54 on 06/12/24 | 483.53 on 06/14/24 | 1,042.66 on 06/14/24 | 41.38 on 06/12/24 |
| 1-Month | |||||
| %Chg | -40.09% since 05/14/24 | -4.77% since 05/17/24 | +6.71% since 05/17/24 | +5.41% since 05/17/24 | -10.23% since 05/17/24 |
| Low | 1.2600 on 06/14/24 | 295.30 on 06/13/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 40.36 on 06/17/24 |
| High | 2.3700 on 05/15/24 | 316.67 on 05/21/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.79 on 05/22/24 |
| 3-Month | |||||
| %Chg | -61.54% since 03/14/24 | +10.68% since 03/15/24 | +16.53% since 03/15/24 | +7.36% since 03/15/24 | -4.29% since 03/15/24 |
| Low | 1.2100 on 04/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 3.5000 on 03/15/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | N/A since 02/16/24 | +8.03% since 12/15/23 | +15.68% since 12/15/23 | +20.52% since 12/15/23 | +12.54% since 12/15/23 |
| Low | 1.2100 on 04/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 838.46 on 12/21/23 | 36.18 on 12/20/23 |
| High | 6.0000 on 02/16/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,497 | 160,190,224 | 124,053,832 | 114,209,984 | 84,244,688 |
| Shares Outstanding, K | 5,767 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -7,380,793 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -2,562,330 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | N/A | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/15/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | N/A | 08/01/24 | 08/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.03 | 31.92 | 27.93 | 10.06 |